Latest THC Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Jason Cassorla | Guggenheim | Maintains | Strong Buy | $271.00 → $283.00 +12.00 (4.4%) | |
| Ann Hynes | Mizuho | Maintains | Buy | $235.00 → $265.00 +30.00 (12.8%) | |
| Whit Mayo | Leerink Partners | Maintains | Buy | $255.00 → $264.00 +9.00 (3.5%) | |
| David Macdonald | Truist | Maintains | Strong Buy | $240.00 → $270.00 +30.00 (12.5%) | |
| Jason Cassorla | Guggenheim | Maintains | Strong Buy | $257.00 → $271.00 +14.00 (5.5%) | |
| Andrew Mok | Barclays | Maintains | Buy | $240.00 → $257.00 +17.00 (7.1%) | |
| Matthew Gillmor | Keybanc | Maintains | Buy | $225.00 → $250.00 +25.00 (11.1%) | |
| Brian Tanquilut | Jefferies | Maintains | Strong Buy | $250.00 → $265.00 +15.00 (6.0%) | |
| A.J. Rice | UBS | Maintains | Strong Buy | $260.00 → $288.00 +28.00 (10.8%) | |
| Ben Hendrix | RBC Capital | Maintains | Buy | $253.00 → $277.00 +24.00 (9.5%) | |
| Ben Hendrix | RBC Capital | Maintains | Buy | $252.00 → $253.00 +1.00 (0.4%) | |
| Ryan Langston | TD Cowen | Maintains | Strong Buy | $233.00 → $230.00 -3.00 (-1.3%) | |
| Stephen Baxter | Wells Fargo | Maintains | Buy | $252.00 → $229.00 -23.00 (-9.1%) |
